A New View of the Spectrum of HER2 Expression and Significance of HER2 Low in Breast Cancer PeerView Oncology 1:25:22 1 year ago 2 187 Скачать Далее
Expert report on tackling resistance to CDK4/6 inhibitors in ER+/HER2-metastatic breast cancer European Society for Medical Oncology (ESMO) 4:50 1 year ago 1 332 Скачать Далее
Overview of the management of HER2-low breast cancer patients ecancer 7:13 1 year ago 117 Скачать Далее
#ESMO21 Expert Video Report on HER2-positive metastatic breast cancer European Society for Medical Oncology (ESMO) 7:30 2 years ago 1 364 Скачать Далее
Questions remaining in the field of HER2-low breast cancer VJOncology 1:33 1 year ago 524 Скачать Далее
Prognostic value of HER2-low status in breast cancer: A systematic review and meta-analysis ecancer 2:30 1 year ago 195 Скачать Далее
#ESMO21 Expert Video Report on HER2-positive early breast cancer European Society for Medical Oncology (ESMO) 8:31 2 years ago 1 338 Скачать Далее
ESMO 2020 Expert Video Report on CDK4 6i in the adjuvant treatment of breast cancer European Society for Medical Oncology (ESMO) 5:32 3 years ago 1 318 Скачать Далее
#ESMO21 Expert Video Report on targeting in HER2-positive metastatic breast and lung cancers European Society for Medical Oncology (ESMO) 5:45 2 years ago 777 Скачать Далее
SSMC- Abu Dhabi Surgical Pathology Journal Club: HER2-low/1+ in Breast Cancer SSMC 1:08:10 9 months ago 65 Скачать Далее
The genomic characterization of primary and metastatic HER2-low breast cancers VJOncology 1:05 1 year ago 51 Скачать Далее
The evolution of HER2-low breast cancer from primary to recurrence VJOncology 0:45 1 year ago 153 Скачать Далее
HER2-low breast cancer: the ESMO Expert Consensus Statements European Society for Medical Oncology (ESMO) 2:02 1 year ago 932 Скачать Далее
Remaining questions on the management of HER2-low breast cancer VJOncology 0:56 1 year ago 152 Скачать Далее
